nodes	percent_of_prediction	percent_of_DWPC	metapath
Methoxsalen—CYP1A1—Dacarbazine—sarcoma	0.335	0.387	CbGbCtD
Methoxsalen—CYP1A2—Dacarbazine—sarcoma	0.15	0.173	CbGbCtD
Methoxsalen—CYP3A4—Thiotepa—sarcoma	0.141	0.163	CbGbCtD
Methoxsalen—CYP1A2—Etoposide—sarcoma	0.0732	0.0845	CbGbCtD
Methoxsalen—CYP3A4—Mitoxantrone—sarcoma	0.0608	0.0702	CbGbCtD
Methoxsalen—CYP3A4—Vincristine—sarcoma	0.0418	0.0483	CbGbCtD
Methoxsalen—CYP3A4—Etoposide—sarcoma	0.0383	0.0443	CbGbCtD
Methoxsalen—CYP3A4—Doxorubicin—sarcoma	0.0262	0.0302	CbGbCtD
Methoxsalen—Leukoderma—Thiotepa—sarcoma	0.00636	0.0476	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Thiotepa—sarcoma	0.00455	0.034	CcSEcCtD
Methoxsalen—Folliculitis—Dactinomycin—sarcoma	0.00427	0.0319	CcSEcCtD
Methoxsalen—Skin exfoliation—Thiotepa—sarcoma	0.00258	0.0193	CcSEcCtD
Methoxsalen—Leukoderma—Epirubicin—sarcoma	0.00256	0.0192	CcSEcCtD
Methoxsalen—Leukoderma—Doxorubicin—sarcoma	0.00237	0.0177	CcSEcCtD
Methoxsalen—Inflammation—Etoposide—sarcoma	0.002	0.015	CcSEcCtD
Methoxsalen—Skin exfoliation—Etoposide—sarcoma	0.00186	0.0139	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Epirubicin—sarcoma	0.00183	0.0137	CcSEcCtD
Methoxsalen—Folliculitis—Epirubicin—sarcoma	0.00173	0.013	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Doxorubicin—sarcoma	0.00169	0.0127	CcSEcCtD
Methoxsalen—Redness—Epirubicin—sarcoma	0.00161	0.0121	CcSEcCtD
Methoxsalen—Folliculitis—Doxorubicin—sarcoma	0.0016	0.012	CcSEcCtD
Methoxsalen—Blister—Epirubicin—sarcoma	0.00151	0.0113	CcSEcCtD
Methoxsalen—Redness—Doxorubicin—sarcoma	0.00149	0.0112	CcSEcCtD
Methoxsalen—Blister—Doxorubicin—sarcoma	0.0014	0.0105	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Vincristine—sarcoma	0.00137	0.0103	CcSEcCtD
Methoxsalen—Depression—Vincristine—sarcoma	0.00134	0.01	CcSEcCtD
Methoxsalen—Arrhythmia—Thiotepa—sarcoma	0.00121	0.00907	CcSEcCtD
Methoxsalen—Erythema—Thiotepa—sarcoma	0.00118	0.00884	CcSEcCtD
Methoxsalen—Herpes simplex—Epirubicin—sarcoma	0.00118	0.00884	CcSEcCtD
Methoxsalen—Erythema—Dactinomycin—sarcoma	0.00117	0.00877	CcSEcCtD
Methoxsalen—Tension—Thiotepa—sarcoma	0.00116	0.00867	CcSEcCtD
Methoxsalen—Nervousness—Thiotepa—sarcoma	0.00115	0.00859	CcSEcCtD
Methoxsalen—Inflammation—Epirubicin—sarcoma	0.00112	0.00839	CcSEcCtD
Methoxsalen—Herpes simplex—Doxorubicin—sarcoma	0.00109	0.00818	CcSEcCtD
Methoxsalen—Ill-defined disorder—Dactinomycin—sarcoma	0.00109	0.00814	CcSEcCtD
Methoxsalen—Malaise—Dactinomycin—sarcoma	0.00106	0.00791	CcSEcCtD
Methoxsalen—Arrhythmia—Mitoxantrone—sarcoma	0.00105	0.00783	CcSEcCtD
Methoxsalen—Skin exfoliation—Epirubicin—sarcoma	0.00104	0.00777	CcSEcCtD
Methoxsalen—Inflammation—Doxorubicin—sarcoma	0.00104	0.00777	CcSEcCtD
Methoxsalen—Erythema—Mitoxantrone—sarcoma	0.00102	0.00763	CcSEcCtD
Methoxsalen—Cramps of lower extremities—Epirubicin—sarcoma	0.001	0.00748	CcSEcCtD
Methoxsalen—Dysgeusia—Mitoxantrone—sarcoma	0.001	0.00748	CcSEcCtD
Methoxsalen—Discomfort—Dactinomycin—sarcoma	0.000987	0.00738	CcSEcCtD
Methoxsalen—Skin exfoliation—Doxorubicin—sarcoma	0.000962	0.00719	CcSEcCtD
Methoxsalen—Infection—Thiotepa—sarcoma	0.000959	0.00717	CcSEcCtD
Methoxsalen—Oedema—Dactinomycin—sarcoma	0.000958	0.00716	CcSEcCtD
Methoxsalen—Infection—Dactinomycin—sarcoma	0.000952	0.00711	CcSEcCtD
Methoxsalen—Ill-defined disorder—Mitoxantrone—sarcoma	0.000948	0.00708	CcSEcCtD
Methoxsalen—Vertigo—Vincristine—sarcoma	0.000942	0.00704	CcSEcCtD
Methoxsalen—Skin disorder—Thiotepa—sarcoma	0.000937	0.00701	CcSEcCtD
Methoxsalen—Cramps of lower extremities—Doxorubicin—sarcoma	0.000926	0.00692	CcSEcCtD
Methoxsalen—Malaise—Mitoxantrone—sarcoma	0.000921	0.00688	CcSEcCtD
Methoxsalen—Discomfort—Mitoxantrone—sarcoma	0.000859	0.00642	CcSEcCtD
Methoxsalen—Oedema—Vincristine—sarcoma	0.000856	0.0064	CcSEcCtD
Methoxsalen—Infection—Vincristine—sarcoma	0.00085	0.00636	CcSEcCtD
Methoxsalen—Dyspepsia—Thiotepa—sarcoma	0.00085	0.00635	CcSEcCtD
Methoxsalen—Oedema—Mitoxantrone—sarcoma	0.000833	0.00623	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Thiotepa—sarcoma	0.000833	0.00623	CcSEcCtD
Methoxsalen—Dysgeusia—Etoposide—sarcoma	0.000832	0.00622	CcSEcCtD
Methoxsalen—Infection—Mitoxantrone—sarcoma	0.000828	0.00619	CcSEcCtD
Methoxsalen—Dermatitis bullous—Epirubicin—sarcoma	0.000827	0.00618	CcSEcCtD
Methoxsalen—Muscle spasms—Etoposide—sarcoma	0.000817	0.00611	CcSEcCtD
Methoxsalen—Skin disorder—Mitoxantrone—sarcoma	0.00081	0.00605	CcSEcCtD
Methoxsalen—Hypotension—Vincristine—sarcoma	0.0008	0.00598	CcSEcCtD
Methoxsalen—Feeling abnormal—Thiotepa—sarcoma	0.000795	0.00595	CcSEcCtD
Methoxsalen—Feeling abnormal—Dactinomycin—sarcoma	0.000789	0.0059	CcSEcCtD
Methoxsalen—Ill-defined disorder—Etoposide—sarcoma	0.000788	0.00589	CcSEcCtD
Methoxsalen—Hypotension—Mitoxantrone—sarcoma	0.000779	0.00582	CcSEcCtD
Methoxsalen—Insomnia—Vincristine—sarcoma	0.000774	0.00579	CcSEcCtD
Methoxsalen—Urticaria—Thiotepa—sarcoma	0.000767	0.00573	CcSEcCtD
Methoxsalen—Malaise—Etoposide—sarcoma	0.000766	0.00573	CcSEcCtD
Methoxsalen—Dermatitis bullous—Doxorubicin—sarcoma	0.000765	0.00572	CcSEcCtD
Methoxsalen—Vertigo—Etoposide—sarcoma	0.000763	0.00571	CcSEcCtD
Methoxsalen—Body temperature increased—Thiotepa—sarcoma	0.000763	0.0057	CcSEcCtD
Methoxsalen—Body temperature increased—Dactinomycin—sarcoma	0.000757	0.00566	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Vincristine—sarcoma	0.000739	0.00552	CcSEcCtD
Methoxsalen—Dyspepsia—Mitoxantrone—sarcoma	0.000734	0.00548	CcSEcCtD
Methoxsalen—Dry skin—Epirubicin—sarcoma	0.000725	0.00542	CcSEcCtD
Methoxsalen—Discomfort—Etoposide—sarcoma	0.000715	0.00534	CcSEcCtD
Methoxsalen—Hypersensitivity—Thiotepa—sarcoma	0.000711	0.00532	CcSEcCtD
Methoxsalen—Hypersensitivity—Dactinomycin—sarcoma	0.000706	0.00528	CcSEcCtD
Methoxsalen—Infection—Etoposide—sarcoma	0.000689	0.00515	CcSEcCtD
Methoxsalen—Feeling abnormal—Mitoxantrone—sarcoma	0.000687	0.00513	CcSEcCtD
Methoxsalen—Pruritus—Thiotepa—sarcoma	0.000683	0.0051	CcSEcCtD
Methoxsalen—Body temperature increased—Vincristine—sarcoma	0.000677	0.00506	CcSEcCtD
Methoxsalen—Skin disorder—Etoposide—sarcoma	0.000673	0.00503	CcSEcCtD
Methoxsalen—Dry skin—Doxorubicin—sarcoma	0.000671	0.00501	CcSEcCtD
Methoxsalen—Urticaria—Mitoxantrone—sarcoma	0.000662	0.00495	CcSEcCtD
Methoxsalen—Body temperature increased—Mitoxantrone—sarcoma	0.000659	0.00493	CcSEcCtD
Methoxsalen—Hypotension—Etoposide—sarcoma	0.000648	0.00484	CcSEcCtD
Methoxsalen—Dizziness—Thiotepa—sarcoma	0.000638	0.00477	CcSEcCtD
Methoxsalen—Hypersensitivity—Vincristine—sarcoma	0.000631	0.00471	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Epirubicin—sarcoma	0.000624	0.00466	CcSEcCtD
Methoxsalen—Hypersensitivity—Mitoxantrone—sarcoma	0.000614	0.00459	CcSEcCtD
Methoxsalen—Rash—Thiotepa—sarcoma	0.000609	0.00455	CcSEcCtD
Methoxsalen—Dermatitis—Thiotepa—sarcoma	0.000608	0.00454	CcSEcCtD
Methoxsalen—Headache—Thiotepa—sarcoma	0.000605	0.00452	CcSEcCtD
Methoxsalen—Rash—Dactinomycin—sarcoma	0.000604	0.00451	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Etoposide—sarcoma	0.000599	0.00447	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Doxorubicin—sarcoma	0.000577	0.00431	CcSEcCtD
Methoxsalen—Nausea—Thiotepa—sarcoma	0.000573	0.00429	CcSEcCtD
Methoxsalen—Feeling abnormal—Etoposide—sarcoma	0.000571	0.00427	CcSEcCtD
Methoxsalen—Nausea—Dactinomycin—sarcoma	0.000569	0.00425	CcSEcCtD
Methoxsalen—Dizziness—Vincristine—sarcoma	0.000566	0.00423	CcSEcCtD
Methoxsalen—Urticaria—Etoposide—sarcoma	0.000551	0.00412	CcSEcCtD
Methoxsalen—Body temperature increased—Etoposide—sarcoma	0.000548	0.0041	CcSEcCtD
Methoxsalen—Rash—Vincristine—sarcoma	0.00054	0.00403	CcSEcCtD
Methoxsalen—Dermatitis—Vincristine—sarcoma	0.000539	0.00403	CcSEcCtD
Methoxsalen—Headache—Vincristine—sarcoma	0.000536	0.00401	CcSEcCtD
Methoxsalen—Rash—Mitoxantrone—sarcoma	0.000526	0.00393	CcSEcCtD
Methoxsalen—Dermatitis—Mitoxantrone—sarcoma	0.000525	0.00392	CcSEcCtD
Methoxsalen—Headache—Mitoxantrone—sarcoma	0.000522	0.0039	CcSEcCtD
Methoxsalen—Hypersensitivity—Etoposide—sarcoma	0.000511	0.00382	CcSEcCtD
Methoxsalen—Nausea—Vincristine—sarcoma	0.000508	0.0038	CcSEcCtD
Methoxsalen—Nausea—Mitoxantrone—sarcoma	0.000495	0.0037	CcSEcCtD
Methoxsalen—Pruritus—Etoposide—sarcoma	0.00049	0.00367	CcSEcCtD
Methoxsalen—Arrhythmia—Epirubicin—sarcoma	0.000489	0.00365	CcSEcCtD
Methoxsalen—Erythema—Epirubicin—sarcoma	0.000476	0.00356	CcSEcCtD
Methoxsalen—Tension—Epirubicin—sarcoma	0.000467	0.00349	CcSEcCtD
Methoxsalen—Dysgeusia—Epirubicin—sarcoma	0.000466	0.00349	CcSEcCtD
Methoxsalen—Nervousness—Epirubicin—sarcoma	0.000462	0.00346	CcSEcCtD
Methoxsalen—Dizziness—Etoposide—sarcoma	0.000458	0.00343	CcSEcCtD
Methoxsalen—Muscle spasms—Epirubicin—sarcoma	0.000458	0.00342	CcSEcCtD
Methoxsalen—Arrhythmia—Doxorubicin—sarcoma	0.000452	0.00338	CcSEcCtD
Methoxsalen—Ill-defined disorder—Epirubicin—sarcoma	0.000442	0.0033	CcSEcCtD
Methoxsalen—Erythema—Doxorubicin—sarcoma	0.000441	0.00329	CcSEcCtD
Methoxsalen—Rash—Etoposide—sarcoma	0.000437	0.00327	CcSEcCtD
Methoxsalen—Dermatitis—Etoposide—sarcoma	0.000437	0.00326	CcSEcCtD
Methoxsalen—Headache—Etoposide—sarcoma	0.000434	0.00325	CcSEcCtD
Methoxsalen—Tension—Doxorubicin—sarcoma	0.000432	0.00323	CcSEcCtD
Methoxsalen—Dysgeusia—Doxorubicin—sarcoma	0.000431	0.00323	CcSEcCtD
Methoxsalen—Malaise—Epirubicin—sarcoma	0.000429	0.00321	CcSEcCtD
Methoxsalen—Nervousness—Doxorubicin—sarcoma	0.000428	0.0032	CcSEcCtD
Methoxsalen—Vertigo—Epirubicin—sarcoma	0.000428	0.0032	CcSEcCtD
Methoxsalen—Muscle spasms—Doxorubicin—sarcoma	0.000424	0.00317	CcSEcCtD
Methoxsalen—Nausea—Etoposide—sarcoma	0.000412	0.00308	CcSEcCtD
Methoxsalen—Ill-defined disorder—Doxorubicin—sarcoma	0.000409	0.00306	CcSEcCtD
Methoxsalen—Discomfort—Epirubicin—sarcoma	0.000401	0.00299	CcSEcCtD
Methoxsalen—Malaise—Doxorubicin—sarcoma	0.000397	0.00297	CcSEcCtD
Methoxsalen—Vertigo—Doxorubicin—sarcoma	0.000396	0.00296	CcSEcCtD
Methoxsalen—Oedema—Epirubicin—sarcoma	0.000389	0.00291	CcSEcCtD
Methoxsalen—Infection—Epirubicin—sarcoma	0.000386	0.00289	CcSEcCtD
Methoxsalen—Skin disorder—Epirubicin—sarcoma	0.000377	0.00282	CcSEcCtD
Methoxsalen—Discomfort—Doxorubicin—sarcoma	0.000371	0.00277	CcSEcCtD
Methoxsalen—Hypotension—Epirubicin—sarcoma	0.000363	0.00271	CcSEcCtD
Methoxsalen—Oedema—Doxorubicin—sarcoma	0.00036	0.00269	CcSEcCtD
Methoxsalen—Infection—Doxorubicin—sarcoma	0.000357	0.00267	CcSEcCtD
Methoxsalen—Insomnia—Epirubicin—sarcoma	0.000351	0.00263	CcSEcCtD
Methoxsalen—Skin disorder—Doxorubicin—sarcoma	0.000349	0.00261	CcSEcCtD
Methoxsalen—Dyspepsia—Epirubicin—sarcoma	0.000342	0.00256	CcSEcCtD
Methoxsalen—Hypotension—Doxorubicin—sarcoma	0.000336	0.00251	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Epirubicin—sarcoma	0.000336	0.00251	CcSEcCtD
Methoxsalen—Insomnia—Doxorubicin—sarcoma	0.000325	0.00243	CcSEcCtD
Methoxsalen—Feeling abnormal—Epirubicin—sarcoma	0.00032	0.00239	CcSEcCtD
Methoxsalen—Dyspepsia—Doxorubicin—sarcoma	0.000317	0.00237	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00031	0.00232	CcSEcCtD
Methoxsalen—Urticaria—Epirubicin—sarcoma	0.000309	0.00231	CcSEcCtD
Methoxsalen—Body temperature increased—Epirubicin—sarcoma	0.000307	0.0023	CcSEcCtD
Methoxsalen—Feeling abnormal—Doxorubicin—sarcoma	0.000296	0.00222	CcSEcCtD
Methoxsalen—Hypersensitivity—Epirubicin—sarcoma	0.000286	0.00214	CcSEcCtD
Methoxsalen—Urticaria—Doxorubicin—sarcoma	0.000286	0.00214	CcSEcCtD
Methoxsalen—Body temperature increased—Doxorubicin—sarcoma	0.000284	0.00212	CcSEcCtD
Methoxsalen—Pruritus—Epirubicin—sarcoma	0.000275	0.00206	CcSEcCtD
Methoxsalen—Hypersensitivity—Doxorubicin—sarcoma	0.000265	0.00198	CcSEcCtD
Methoxsalen—Dizziness—Epirubicin—sarcoma	0.000257	0.00192	CcSEcCtD
Methoxsalen—Pruritus—Doxorubicin—sarcoma	0.000254	0.0019	CcSEcCtD
Methoxsalen—Rash—Epirubicin—sarcoma	0.000245	0.00183	CcSEcCtD
Methoxsalen—Dermatitis—Epirubicin—sarcoma	0.000245	0.00183	CcSEcCtD
Methoxsalen—Headache—Epirubicin—sarcoma	0.000243	0.00182	CcSEcCtD
Methoxsalen—Dizziness—Doxorubicin—sarcoma	0.000238	0.00178	CcSEcCtD
Methoxsalen—Nausea—Epirubicin—sarcoma	0.000231	0.00173	CcSEcCtD
Methoxsalen—Rash—Doxorubicin—sarcoma	0.000227	0.00169	CcSEcCtD
Methoxsalen—Dermatitis—Doxorubicin—sarcoma	0.000227	0.00169	CcSEcCtD
Methoxsalen—Headache—Doxorubicin—sarcoma	0.000225	0.00168	CcSEcCtD
Methoxsalen—Nausea—Doxorubicin—sarcoma	0.000214	0.0016	CcSEcCtD
